✦ LIBER ✦

Treatment of disseminated malignant melanoma with high-dose oral BCG

✍ Scribed by Antonio Drauzio Varella; Dino Carlos Bandiera; Antonio R. De Amorim Sr.; Luciano A. Calvis; Ivan Oliveira Santos; Narcisco Escaleira; Fernando Gentil

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 1010 KB
Volume: 48
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19810915)48:6<1353::aid-cncr2820480617>3.0.co;2-n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoimmunotherapy of disseminated malig

Chemoimmunotherapy of disseminated malignant melanoma with DTIC-BCG, transfer factor + melphalan

✍ Max A. Schwarz; Jordan U. Gutterman; Michael A. Burgess; Lance K. Heilbrun; Will 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 960 KB

Radiation therapy of malignant melanoma.

Radiation therapy of malignant melanoma. Experience with high individual treatment doses

✍ Hans J. Habermalz; James J. Fischer 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 2 views

Adjuvant treatment of malignant melanoma

Adjuvant treatment of malignant melanoma with DTIC + estracyt or BCG

✍ Dr. Constantine P. Karakousis; Lawrence J. Emrich 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB

Eighty-two patients with invasive malignant melanoma and no distant metastases were prospectively randomized following their surgical treatment to 1) observation; 2) chemotherapy with Dacarbazine (DTIC) 200 mg/M2 I.V. daily X 5 every 4 weeks and Estracyt 15 mg/kg orally daily for 1 year; and 3) immu

Phase II study of high-dose tamoxifen (N

Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma

✍ Edward T. Creagan; James N. Ingle; David L. Ahmann; Stephanie J. Green 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 3 views

Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reas

Combination chemotherapy plus BCG in the

Combination chemotherapy plus BCG in the treatment of disseminated malignant melanoma: A southwest oncology group study

✍ Costanzi, John J. ;Al-Sarraf, Muhyi ;Groppe, Carl ;Bottomley, Richard ;Fabian, C 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

## Abstract The Southwest Oncology Group performed a randomized study comparing combination chemotherapy alone versus combination chemotherapy plus BCG versus DTIC plus BCG in the treatment of disseminated malignant melanoma. A 31% response rate was noted with combination chemotherapy alone, a 27%

Treatment of advanced malignant melanoma

Treatment of advanced malignant melanoma with high dose methotrexate and folinic acid rescue

✍ Leahy, Michael F. ;Silver, Hulbert K. B. ;Klimo, Paul ;Hall, Thomas C. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB

## Abstract Twenty‐eight patients with advanced malignant melanoma were treated with high dose methotrexate (HDMTX) and folinic acid (FA) rescue. Nineteen patients were treated with 6‐hour infusions and 10 patients with 24‐hour infusions. One patient in the 6‐hour infusion group showed a partial re